Deep Track Capital, Lp Top Holdings and 13F Report (2026) About Deep Track Capital, LpInvestment ActivityDeep Track Capital, Lp has $6.87 billion in total holdings as of June 30, 2026.Deep Track Capital, Lp owns shares of 66 different stocks, but just 29 companies or ETFs make up 80% of its holdings.Approximately 26.17% of the portfolio was purchased this quarter.About 34.13% of the portfolio was sold this quarter.This quarter, Deep Track Capital, Lp has purchased 63 new stocks and bought additional shares in 22 stocks.Deep Track Capital, Lp sold shares of 15 stocks and completely divested from 15 stocks this quarter.Largest Holdings Guardant Health $509,098,599Immunovant $359,914,548Structure Therapeutics $254,399,664Vaxcyte $249,959,000Alnylam Pharmaceuticals $248,349,750 Largest New Holdings this Quarter 02043Q107 - Alnylam Pharmaceuticals $248,349,750 Holding423494103 - HEMAB THERAPEUTICS HLDGS INC $132,304,876 HoldingG3855L106 - GH Research $89,600,018 Holding91307C102 - United Therapeutics $66,978,857 Holding05338F306 - AVALO THERAPEUTICS INC $66,712,800 Holding Largest Purchases this Quarter Alnylam Pharmaceuticals 825,000 shares (about $248.35M)VERADERMICS INC 1,500,000 shares (about $184.41M)Genmab A/S 4,986,750 shares (about $136.99M)HEMAB THERAPEUTICS HLDGS INC 3,602,093 shares (about $132.30M)BioMarin Pharmaceutical 2,157,481 shares (about $123.45M) Largest Sales this Quarter Axsome Therapeutics 400,000 shares (about $97.91M)Immunovant 2,185,820 shares (about $84.22M)Cytokinetics 674,320 shares (about $57.45M)MBX BIOSCIENCES INC 1,025,000 shares (about $56.58M)Immunocore 1,620,666 shares (about $51.46M) Sector Allocation Over TimeMap of 500 Largest Holdings ofDeep Track Capital, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorGHGuardant Health$509,098,599$8,262,302 â–²1.6%3,393,3127.4%HealthcareIMVTImmunovant$359,914,548$84,219,645 â–¼-19.0%9,341,1515.2%HealthcareGPCRStructure Therapeutics$254,399,664$24,700,222 â–²10.8%4,740,0723.7%HealthcarePCVXVaxcyte$249,959,0000.0%4,300,0003.6%HealthcareALNYAlnylam Pharmaceuticals$248,349,750$248,349,750 â–²New Holding825,0003.6%HealthcareVERADERMICS INC$245,880,000$184,410,000 â–²300.0%2,000,0003.6%COMMON STOCKGMABGenmab A/S$237,615,500$136,986,023 â–²136.1%8,650,0003.5%HealthcareTARSTarsus Pharmaceuticals$230,786,378$4,202,378 â–²1.9%3,666,7683.4%HealthcareNUVLNuvalent$220,240,267$50,264,253 â–²29.6%1,783,3223.2%HealthcareALKSAlkermes$209,580,000$21,465,026 â–²11.4%4,000,0003.1%HealthcareOCULOcular Therapeutix$193,319,2890.0%19,686,2822.8%HealthcareBMRNBioMarin Pharmaceutical$189,254,063$123,451,063 â–²187.6%3,307,4812.8%HealthcareNRIXNurix Therapeutics$187,686,398$33,750,779 â–²21.9%7,736,4552.7%HealthcareORUKA THERAPEUTICS INC$183,297,420$10,297,680 â–¼-5.3%1,926,0002.7%COMALUMIS INC$178,648,422$11,932,401 â–¼-6.3%6,348,5582.6%COMIONSIonis Pharmaceuticals$174,438,000$19,822,500 â–²12.8%2,200,0002.5%HealthcareCMPSCompass Pathways$172,085,1680.0%12,161,4962.5%HealthcareVERAVera Therapeutics$171,640,000$4,551,335 â–¼-2.6%4,000,0002.5%HealthcareAXSMAxsome Therapeutics$171,339,000$97,908,000 â–¼-36.4%700,0002.5%HealthcareMLTXMoonLake Immunotherapeutics$136,271,017$11,490,454 â–²9.2%6,999,0252.0%HealthcareHEMAB THERAPEUTICS HLDGS INC$132,304,876$132,304,876 â–²New Holding3,602,0931.9%COM SHSTNGXTango Therapeutics$131,292,000$45,327,000 â–²52.7%4,200,0001.9%HealthcareDEFINIUM THERAPEUTICS INC$129,360,000$11,760,000 â–¼-8.3%2,750,0001.9%COM SHSGRAIL INC$125,271,627$7,656,276 â–²6.5%1,834,9441.8%COMBICARA THERAPEUTICS INC$121,729,000$1,113,375 â–²0.9%4,100,0001.8%COMMAZE THERAPEUTICS INC$111,379,859$7,609,409 â–²7.3%3,732,5691.6%COMCLDXCelldex Therapeutics$109,365,809$61,588,950 â–²128.9%2,939,1511.6%HealthcareLB PHARMACEUTICALS INC$108,815,2540.0%3,352,8041.6%COM SHSMBX BIOSCIENCES INC$95,637,809$56,580,000 â–¼-37.2%1,732,5691.4%COMGHRSGH Research$89,600,018$89,600,018 â–²New Holding3,333,3341.3%HealthcareCOGTCogent Biosciences$77,400,000$38,700,000 â–²100.0%2,000,0001.1%HealthcareATAIBECKLEY INC$75,979,919$12,739,919 â–²20.1%14,417,4421.1%COM SHSUTHRUnited Therapeutics$66,978,857$66,978,857 â–²New Holding123,6161.0%HealthcareAVALO THERAPEUTICS INC$66,712,800$66,712,800 â–²New Holding3,610,0001.0%COM NEWVRDNViridian Therapeutics$65,998,634$40,391,883 â–²157.7%3,592,7401.0%HealthcareCYTKCytokinetics$59,633,000$57,445,321 â–¼-49.1%700,0000.9%HealthcareALTAltimmune$58,520,000$58,520,000 â–²New Holding19,250,0000.9%HealthcarePSNLPersonalis$53,600,000$13,400,000 â–²33.3%4,000,0000.8%HealthcareACRSAclaris Therapeutics$49,435,0500.0%9,345,0000.7%HealthcareCRMDCorMedix$49,251,4970.0%6,274,0760.7%HealthcareWGSGeneDx$48,055,000$48,055,000 â–²New Holding700,0000.7%HealthcareHROWHarrow$41,153,430$41,153,430 â–²New Holding969,0000.6%HealthcareCRVSCorvus Pharmaceuticals$37,229,569$5,976 â–²0.0%2,491,9390.5%HealthcareSLDBSolid Biosciences$35,614,9690.0%3,565,0620.5%HealthcareBEAMBeam Therapeutics$34,320,000$6,151,345 â–²21.8%1,000,0000.5%HealthcareDYNE THERAPEUTICS INC$33,315,000$11,105,000 â–¼-25.0%1,500,0000.5%COMIMMXImmix Biopharma$28,610,250$28,610,250 â–²New Holding2,775,0000.4%HealthcareX4 PHARMACEUTICALS INC$27,453,795$2,151,833 â–¼-7.3%5,878,7570.4%COM NEWSTTKShattuck Labs$25,724,734$25,724,734 â–²New Holding3,706,7340.4%HealthcareMNKDMannKind$25,560,000$25,560,000 â–²New Holding6,000,0000.4%HealthcareIPSCCentury Therapeutics$23,183,480$61,495 â–¼-0.3%9,462,6450.3%HealthcareGENERATE BIOMEDICINES INC$22,501,459$22,501,459 â–²New Holding1,333,8150.3%COM SHSVSTMVerastem$21,930,0470.0%5,740,8500.3%HealthcareKURAKura Oncology$21,704,858$7,294,798 â–¼-25.2%1,978,5650.3%HealthcareENTAEnanta Pharmaceuticals$21,055,955$7,475,166 â–¼-26.2%1,444,1670.3%HealthcareNEKTAR THERAPEUTICS$20,943,000$20,943,000 â–²New Holding300,0000.3%COM NEWOLMAOlema Pharmaceuticals$18,765,000$18,765,000 â–²New Holding1,500,0000.3%HealthcareKAILERA THERAPEUTICS INC$15,421,000$15,421,000 â–²New Holding700,0000.2%COMMON STOCKKARDIGAN INC$14,310,000$14,310,000 â–²New Holding600,0000.2%COMELVNEnliven Therapeutics$11,418,750$11,418,750 â–²New Holding225,0000.2%HealthcarePROMIS NEUROSCIENCES INC$10,997,2200.0%835,6550.2%COM SHSIMCRImmunocore$9,881,172$51,456,148 â–¼-83.9%311,2180.1%HealthcareXNCRXencor$9,556,171$9,556,171 â–²New Holding593,5510.1%HealthcareCNTXContext Therapeutics$4,109,5810.0%7,419,3550.1%HealthcareIVAInventiva$3,024,000$1,596,872 â–¼-34.6%800,0000.0%HealthcareALIGOS THERAPEUTICS INC$2,562,5150.0%444,1100.0%COM NEWXBISPDR S&P Biotech ETF$0$1,277,300,000 â–¼-100.0%00.0%ETFAPLSApellis Pharmaceuticals$0$182,337,406 â–¼-100.0%00.0%HealthcareCNTACentessa Pharmaceuticals$0$125,437,389 â–¼-100.0%00.0%HealthcareBBIOBridgeBio Pharma$0$62,485,706 â–¼-100.0%00.0%HealthcareTERNTerns Pharmaceuticals$0$56,614,795 â–¼-100.0%00.0%HealthcareGERNGeron$0$47,263,214 â–¼-100.0%00.0%HealthcareANIPANI Pharmaceuticals$0$46,140,000 â–¼-100.0%00.0%HealthcareSLNOSoleno Therapeutics$0$36,115,211 â–¼-100.0%00.0%HealthcareENGENE HOLDINGS INC$0$29,811,265 â–¼-100.0%00.0%COMAPOGEE THERAPEUTICS INC$0$23,988,450 â–¼-100.0%00.0%COMJANXJanux Therapeutics$0$16,503,331 â–¼-100.0%00.0%HealthcareCRESCENT BIOPHARMA INC.$0$8,334,212 â–¼-100.0%00.0%COMLRMRLarimar Therapeutics$0$6,750,000 â–¼-100.0%00.0%HealthcareCYBIN INC$0$6,303,058 â–¼-100.0%00.0%COM NEWBILLIONTOONE INC$0$3,947,000 â–¼-100.0%00.0%CL AShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
